7 June 2023
European Commission authorises GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for older adults · Authorisation will help protect adults 60 years of age and older…
GSK receives US FDA file acceptance for Jemperli (dostarlimab) plus chemotherapy for the treatment of dMMR/MSI-H primary advanced or recurrent endometrial cancer · Submission accepted for Priority…
6 June 2023
HIGHLIGHTS – Total return to shareholders 16.0% (Benchmark 8.6%) – Ordinary dividend 4.0p Legal Entity Identifier: 549300D8SPJFHBDGXS57 Information disclosed in accordance with DTR 4.1 CHAIR’S STATEMENT Introduction…
2023 H1 Pre-Close Trading Update: On track to meet full year guidance 06 June 2023 Trading update – ahead of closed period commencing 26 June…
6 June 2023 B.P. Marsh & Partners Plc (“B.P. Marsh”, the “Company” or the “Group”) Use of Proceeds of Sale (£51.5m) and Strategy Update…
2 June 2023
Anpario PLC (“Anpario”, the “Company” or the “Group”) Proposed Tender Offer of up to 4,000,000 Ordinary Shares at 225 pence per Ordinary Share Anpario…
1 June 2023
AVI GLOBAL TRUST PLC (‘AGT’ or the ‘Company’) LEI: 213800QUODCLWWRVI968 Announcement of unaudited results for the half-year ended 31 March 2023 Half Year Financial Report…
1 June 2023 Lynparza plus abiraterone approved in the US for the treatment ofBRCA-mutated metastatic castration-resistant prostate cancer Lynparza combination reduced the risk of disease…